OTLK icon

Outlook Therapeutics
OTLK

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$3.83
602% upside
High target

3 analyst ratings

positive
2  neutral
67%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Chardan Capital
Chardan Capital
Daniil Gataulin
5 Jan ‘26 13 days ago
HC Wainwright & Co
HC Wainwright & Co
Douglas Tsao
0% 1-yr OTLK win rate
2 Jan ‘26 16 days ago
Ascendiant Capital
Ascendiant Capital
Edward Woo
50% 1-yr OTLK win rate
22 Dec ‘25 27 days ago